ARCHIVES

Phase III Kyprolis Trial Fails OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

BCTF July, Sept. Meetings To Develop New Research Ideas

December 3, 1976

Pitot Named New NCAB Chairman

May 4, 1979

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

In Brief: Ames, Rowley, Win National Science Medals; New Building Planned for Pittsburgh Center

January 8, 1999